Rheumatoid arthritis therapy after tumor necrosis factor and interleukin‐1 blockade
Open Access
- 8 December 2003
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 48 (12) , 3308-3319
- https://doi.org/10.1002/art.11358
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- A role for Toll in autoimmunityNature Immunology, 2002
- NF-κB at the crossroads of life and deathNature Immunology, 2002
- Induction and Suppression of Collagen-Induced Arthritis Is Dependent on Distinct Fcγ ReceptorsThe Journal of Experimental Medicine, 2000
- Development and validation of the european league against rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary american college of rheumatology and the world health organization/international league against rheumatism criteriaArthritis & Rheumatism, 1996
- The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trialsArthritis & Rheumatism, 1993
- Release of cartilage macromolecules into the synovial fluid in patients with acute and prolonged phases of reactive arthritisArthritis & Rheumatism, 1993
- Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophagesClinical Immunology and Immunopathology, 1992
- Immunohistochemical analysis of synovial membranes from inflammatory and non-inflammatory arthritides: scarcity of CD5 positive B cells and IL2 receptor bearing T cellsPathology, 1992
- Rheumatoid ArthritisNew England Journal of Medicine, 1990
- The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritisArthritis & Rheumatism, 1987